| Issue Date | Title | Author(s) |
| 2017-11-07 | Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer. | Valdés-Mora, F; Gould, CM; Colino-Sanguino, Y; Qu, W; Song, JZ; Taylor, KM; Buske, FA; Statham, AL; Nair, SS; Armstrong, NJ; Kench, JG; Lee, KML; Horvath, LG; Qiu, M; Ilinykh, A; Yeo-Teh, NS; Gallego-Ortega, D; Stirzaker, C; Clark, SJ |
| 2019-06-20 | Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: A cluster randomised trial protocol | Morrow, A; Hogden, E; Kang, YJ; Steinberg, J; Canfell, K; Solomon, MJ; Kench, JG; Gill, AJ; Shaw, T; Pachter, N; Parkinson, B; Wolfenden, L; Mitchell, G; Macrae, F; Tucker, K; Taylor, N |
| 2009-01-01 | Expression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic Cancer | Biankin, AV; Kench, JG; Colvin, EK; Segara, D; Scarlett, CJ; Nguyen, NQ; Chang, DK; Morey, AL; Lee, CS; Pinese, M; Kuo, SCL; Susanto, JM; Cosman, PH; Lindeman, GJ; Visvader, JE; Nguyen, TV; Merrett, ND; Warusavitarne, J; Musgrove, EA; Henshall, SM; Sutherland, RL |
| 2007-01-25 | Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions | Oakes, SR; Robertson, FG; Kench, JG; Gardiner-Garden, M; Wand, MP; Green, JE; Ormandy, CJ |
| 2022-05-04 | Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals. | Steinberg, J; Chan, P; Hogden, E; Tiernan, G; Morrow, A; Kang, Y-J; He, E; Venchiarutti, R; Titterton, L; Sankey, L; Pearn, A; Nichols, C; McKay, S; Hayward, A; Egoroff, N; Engel, A; Gibbs, P; Goodwin, A; Harris, M; Kench, JG; Pachter, N; Parkinson, B; Pockney, P; Ragunathan, A; Smyth, C; Solomon, M; Steffens, D; Toh, JWT; Wallace, M; Canfell, K; Gill, A; Macrae, F; Tucker, K; Taylor, N |
| 2013-01-01 | Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27 | Young, JA; Ting, KK; Li, J; Moller, T; Dunn, L; Lu, Y; Lay, AJ; Moses, J; Prado-Lourenço, L; Khachigian, LM; Ng, M; Gregory, PA; Goodall, GJ; Tsykin, A; Lichtenstein, I; Hahn, CN; Tran, N; Shackel, N; Kench, JG; McCaughan, G; Vadas, MA; Gamble, JR |
